228 related articles for article (PubMed ID: 30996153)
21. Methionine-PET to differentiate between brain lesions appearing similar on conventional CT/MRI scans.
Ohmura K; Ikegame Y; Yano H; Shinoda J; Iwama T
J Neuroimaging; 2023; 33(5):837-844. PubMed ID: 37246342
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of ¹¹C-methionine positron emission tomography for treatment-decision making in cases of non-enhancing glioma-like brain lesions.
Watanabe A; Muragaki Y; Maruyama T; Shinoda J; Okada Y
J Neurooncol; 2016 Feb; 126(3):577-83. PubMed ID: 26612734
[TBL] [Abstract][Full Text] [Related]
23. Methyl-[11C]- l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma.
Kracht LW; Friese M; Herholz K; Schroeder R; Bauer B; Jacobs A; Heiss WD
Eur J Nucl Med Mol Imaging; 2003 Jun; 30(6):868-73. PubMed ID: 12692687
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy.
Terakawa Y; Tsuyuguchi N; Iwai Y; Yamanaka K; Higashiyama S; Takami T; Ohata K
J Nucl Med; 2008 May; 49(5):694-9. PubMed ID: 18413375
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of volume-based measurements on (11)C-methionine PET in glioma patients.
Kobayashi K; Hirata K; Yamaguchi S; Manabe O; Terasaka S; Kobayashi H; Shiga T; Hattori N; Tanaka S; Kuge Y; Tamaki N
Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1071-80. PubMed ID: 25852010
[TBL] [Abstract][Full Text] [Related]
26. Semiquantitative analysis of C-11 methionine PET may distinguish brain tumor recurrence from radiation necrosis even in small lesions.
Okamoto S; Shiga T; Hattori N; Kubo N; Takei T; Katoh N; Sawamura Y; Nishijima K; Kuge Y; Tamaki N
Ann Nucl Med; 2011 Apr; 25(3):213-20. PubMed ID: 21188660
[TBL] [Abstract][Full Text] [Related]
27. Positron emission tomography with ([11C]methyl)-L-methionine, [11C]D-glucose, and [68Ga]EDTA in supratentorial tumors.
Ericson K; Lilja A; Bergström M; Collins VP; Eriksson L; Ehrin E; von Holst H; Lundqvist H; Långsrom B B; Mosskin M
J Comput Assist Tomogr; 1985; 9(4):683-9. PubMed ID: 3926834
[TBL] [Abstract][Full Text] [Related]
28. Aquaporin Positron Emission Tomography Differentiates Between Grade III and IV Human Astrocytoma.
Suzuki Y; Nakamura Y; Yamada K; Kurabe S; Okamoto K; Aoki H; Kitaura H; Kakita A; Fujii Y; Huber VJ; Igarashi H; Kwee IL; Nakada T
Neurosurgery; 2018 Jun; 82(6):842-846. PubMed ID: 28645205
[TBL] [Abstract][Full Text] [Related]
29. [Combined use of positron emission tomography with (18)F-fluorodeoxyglucose and (11)C-methionine for preoperative evaluation of gliomas].
Yamaguchi S; Terasaka S; Kobayashi H; Narita T; Hirata K; Shiga S; Usui R; Tanaka S; Kubota K; Murata J; Asaoka K
No Shinkei Geka; 2010 Jul; 38(7):621-8. PubMed ID: 20628188
[TBL] [Abstract][Full Text] [Related]
30. Correlation of amino-acid uptake using methionine PET and histological classifications in various gliomas.
Torii K; Tsuyuguchi N; Kawabe J; Sunada I; Hara M; Shiomi S
Ann Nucl Med; 2005 Dec; 19(8):677-83. PubMed ID: 16444993
[TBL] [Abstract][Full Text] [Related]
31. Differential diagnosis between radiation necrosis and glioma progression using sequential proton magnetic resonance spectroscopy and methionine positron emission tomography.
Nakajima T; Kumabe T; Kanamori M; Saito R; Tashiro M; Watanabe M; Tominaga T
Neurol Med Chir (Tokyo); 2009 Sep; 49(9):394-401. PubMed ID: 19779283
[TBL] [Abstract][Full Text] [Related]
32. [Dynamic11C-methionine PET/CT in differential diagnosis of brain gliomas].
Vikhrova NB; Kalaeva DB; Postnov AA; Khokhlova EV; Konakova TA; Batalov AI; Pogosbekyan EL; Pronin IN
Zh Vopr Neirokhir Im N N Burdenko; 2021; 85(3):5-13. PubMed ID: 34156203
[TBL] [Abstract][Full Text] [Related]
33. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U
Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081
[TBL] [Abstract][Full Text] [Related]
34. Value of 18F-FET PET in Patients With Suspected Tumefactive Demyelinating Disease-Preliminary Experience From a Retrospective Analysis.
Barbagallo M; Albatly AA; Schreiner S; Hayward-Könnecke HK; Buck A; Kollias SS; Huellner MW
Clin Nucl Med; 2018 Nov; 43(11):e385-e391. PubMed ID: 30153143
[TBL] [Abstract][Full Text] [Related]
35. Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study.
Altintas A; Petek B; Isik N; Terzi M; Bolukbasi F; Tavsanli M; Saip S; Boz C; Aydin T; Arici-Duz O; Ozer F; Siva A
Mult Scler; 2012 Oct; 18(10):1448-53. PubMed ID: 22419670
[TBL] [Abstract][Full Text] [Related]
36. Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology.
Kracht LW; Miletic H; Busch S; Jacobs AH; Voges J; Hoevels M; Klein JC; Herholz K; Heiss WD
Clin Cancer Res; 2004 Nov; 10(21):7163-70. PubMed ID: 15534088
[TBL] [Abstract][Full Text] [Related]
37. Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI.
Kim YH; Oh SW; Lim YJ; Park CK; Lee SH; Kang KW; Jung HW; Chang KH
Clin Neurol Neurosurg; 2010 Nov; 112(9):758-65. PubMed ID: 20619531
[TBL] [Abstract][Full Text] [Related]
38. [Utility of 11C-methionine PET/CT in neuro-oncology].
Casas Parera I; Igirio Gamero JL; Blumenkrantz Y; Bruno G; Báez A; Tafur Canabal JG; Báez M; Kuchkaryan V
Medicina (B Aires); 2013; 73(3):201-6. PubMed ID: 23732194
[TBL] [Abstract][Full Text] [Related]
39. Positron emission tomography (11)C-methionine and survival in patients with low-grade gliomas.
Ribom D; Eriksson A; Hartman M; Engler H; Nilsson A; Långström B; Bolander H; Bergström M; Smits A
Cancer; 2001 Sep; 92(6):1541-9. PubMed ID: 11745233
[TBL] [Abstract][Full Text] [Related]
40. Functional imaging of a large demyelinating lesion.
Padma MV; Adineh M; Pugar K; Mukherjee J; Satter M; Shi B; Dunigan K; Bidwell K; Ezzeddine B; Mantil J
J Clin Neurosci; 2005 Feb; 12(2):176-8. PubMed ID: 15749424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]